Looking for a Blood Epigenetic Signature to Predict Female Infertility

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-43
SponsorUniversità Vita-Salute San Raffaele

About this trial

The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.

Eligibility criteria

Qualifiers

18< age <43, Infertile woman undergoing ART, recurrent pregnancy loss

Disqualifiers

age < 18 or > 44, previous ovarian surgery, severe male factor infertility

Trial design

Treatments tested in this trial

  • search for epigenetic profile of infertility

Treatment groups

1,456 Participants
are divided into 4 treatment groups